Last reviewed · How we verify
Fluticasone plus salmeterol — Competitive Intelligence Brief
marketed
Small molecule
Live · refreshed every 30 min
Target snapshot
Fluticasone plus salmeterol (Fluticasone plus salmeterol) — JHSPH Center for Clinical Trials.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Fluticasone plus salmeterol TARGET | Fluticasone plus salmeterol | JHSPH Center for Clinical Trials | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Fluticasone plus salmeterol CI watch — RSS
- Fluticasone plus salmeterol CI watch — Atom
- Fluticasone plus salmeterol CI watch — JSON
- Fluticasone plus salmeterol alone — RSS
Cite this brief
Drug Landscape (2026). Fluticasone plus salmeterol — Competitive Intelligence Brief. https://druglandscape.com/ci/fluticasone-plus-salmeterol. Accessed 2026-06-10.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing